TaiDoc Technology Corporation (TPE:4736)
130.50
-11.00 (-7.77%)
Sep 4, 2025, 1:30 PM CST
TaiDoc Technology Revenue
TaiDoc Technology had revenue of 1.12B TWD in the quarter ending June 30, 2025, a decrease of -3.64%. This brings the company's revenue in the last twelve months to 4.50B, up 4.08% year-over-year. In the year 2024, TaiDoc Technology had annual revenue of 4.64B, down -3.46%.
Revenue (ttm)
4.50B
Revenue Growth
+4.08%
P/S Ratio
2.77
Revenue / Employee
6.88M
Employees
654
Market Cap
12.45B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.64B | -166.10M | -3.46% |
Dec 31, 2023 | 4.81B | -4.82B | -50.07% |
Dec 31, 2022 | 9.63B | 3.13B | 48.26% |
Dec 31, 2021 | 6.49B | 589.73M | 9.99% |
Dec 31, 2020 | 5.90B | 1.77B | 42.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 87.67M |
Center Laboratories | 1.60B |